Vancomycin in Total Knee Arthroplasty (TKA)

This study is looking at different ways to give vancomycin, an antibiotic, to prevent infections after total knee replacement surgery (TKA). Researchers want to see if injecting vancomycin directly into the joint (intraarticular) works as well as injecting it into the bone (intraosseous). The goal is to find a method that is just as effective but might involve fewer wounds, less time, and lower costs. You might be able to join if you are over 18, having your first knee replacement at UC San Diego Health, and don't have certain health conditions like a high BMI, uncontrolled diabetes, or allergies to the study medications. The main thing they will measure is how much vancomycin is found in your bone, joint tissue, fat, and blood during surgery. The study plans to enroll 30 participants, and its current status is unclear.

Study design
This interventional study plans to enroll 30 participants. It is comparing two ways of giving vancomycin.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary measurements are taken during surgery (intraoperative).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07282782

Vancomycin in TKAs

Recruiting
PHASE4Ages 18+InterventionalPrevention
University of California, San Diego
~30 participants
Updated 2026-06-03 on ClinicalTrials.gov
What's tested:Vancomycin

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Concentration of vancomycin in bone, synovial tissue, subcutaneous fat and serum blood
Measured over Intraoperative
Total Knee Arthroplasty
1 sites across 1 states
California1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any patient over the age of 18 years of age receiving treatment at UC San Diego Health
Undergoing primary unilateral TKA
Ability to provide consent

Exclusion

previous surgery on the knee (with the exception of arthroscopy)
BMI \> 35
contraindication to receiving vancomycin, cefepime or cefazolin (ie, allergy, etc)
diabetics with A1c\>7.5% (unless controlled fructosamine)
immunocompromised or immunosuppressed patients (HIV, Hepatitis C, end stage renal disease (ESRD), post transplant, chemotherapy or radiation therapy within 6 months of surgery, immunomodulating meducations)
no history of active infections
no history of chronic kidney disease
  • Concentration of vancomycin in bone, synovial tissue, subcutaneous fat and serum bloodIntraoperative